Interest in the study remains very high among the Netterson community, and in fact, just yesterday, a patient traveled almost the full length of the country to get to our Boston clinical site, where he will be screened today for participation in the study.

Nov 10, 2022 / CEO / receipt, needs a key / Michael Munters, CEO | earnings call 2022-11-10 | transcript b554d66a-2c4f-433e-9e78-4aeabdd6b04b | chars 4727-4983 | segment 4